Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Caussé

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Medical Research and Opinion|January 13, 2012
The Bowel Function Index: a new validated scale for assessing opioid-induced constipationPhilippe Ducrotté, Christian Caussé
Expert Review of Gastroenterology & Hepatology|September 14, 2011
Constipation assessment scales in adults: a literature review including the new Bowel Function IndexBenoît Coffin, Christian Caussé
Sleep Medicine|October 22, 2025
An overview of longitudinal data analyses in sleep researchOphélie Coiffier, Ina Jandric, Christian Caussé, et al.
Sleep Medicine|February 18, 2025
Efficacy and safety of pitolisant in residual excessive daytime sleepiness for patients with obstructive sleep apnea adhering to continuous positive airway pressure therapy in the HAROSA studies: An individual patient meta-analytical approachDries Testelmans, Philippe Lehert, Jerryll Asin, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 25, 2022
Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European viewSonya Craig, Jean-Louis Pépin, Winfried Randerath, et al.
Chest|November 18, 2023
Long-Term Efficacy and Safety of Pitolisant for Residual Sleepiness Due to OSAJean-Louis Pépin, Valérie Attali, Christian Caussé, et al.
Sleep Medicine|May 8, 2024
Multidimensional phenotyping to distinguish among distinct obstructive sleep apnea, chronic obstructive pulmonary disease, and overlap syndrome phenotypesOphélie Coiffier, Pasquale Tondo, Marie Joyeux-Faure, et al.
The Lancet. Neurology|March 17, 2023
Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trialYves Dauvilliers, Michel Lecendreux, Gert Jan Lammers, et al.
Eclinicalmedicine|September 30, 2024
Comparative efficacy, safety and benefit/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysisJean-Louis Pépin, Philippe Lehert, Raoua Ben Messaoud, et al.
Annals of the American Thoracic Society|September 23, 2025
Home Blood Pressure Trajectories During 6 Months of Continuous Positive Airway Pressure Therapy: Results from the eMEUSE-SANTE and SLEEPCONNECT ClinicOphélie Coiffier, Sébastien Bailly, Marie Joyeux-Faure, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Medical Research and Opinion|January 13, 2012
The Bowel Function Index: a new validated scale for assessing opioid-induced constipationPhilippe Ducrotté, Christian Caussé
Expert Review of Gastroenterology & Hepatology|September 14, 2011
Constipation assessment scales in adults: a literature review including the new Bowel Function IndexBenoît Coffin, Christian Caussé
Sleep Medicine|October 22, 2025
An overview of longitudinal data analyses in sleep researchOphélie Coiffier, Ina Jandric, Christian Caussé, et al.
Sleep Medicine|February 18, 2025
Efficacy and safety of pitolisant in residual excessive daytime sleepiness for patients with obstructive sleep apnea adhering to continuous positive airway pressure therapy in the HAROSA studies: An individual patient meta-analytical approachDries Testelmans, Philippe Lehert, Jerryll Asin, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 25, 2022
Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European viewSonya Craig, Jean-Louis Pépin, Winfried Randerath, et al.
Chest|November 18, 2023
Long-Term Efficacy and Safety of Pitolisant for Residual Sleepiness Due to OSAJean-Louis Pépin, Valérie Attali, Christian Caussé, et al.
Sleep Medicine|May 8, 2024
Multidimensional phenotyping to distinguish among distinct obstructive sleep apnea, chronic obstructive pulmonary disease, and overlap syndrome phenotypesOphélie Coiffier, Pasquale Tondo, Marie Joyeux-Faure, et al.
The Lancet. Neurology|March 17, 2023
Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trialYves Dauvilliers, Michel Lecendreux, Gert Jan Lammers, et al.
Eclinicalmedicine|September 30, 2024
Comparative efficacy, safety and benefit/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysisJean-Louis Pépin, Philippe Lehert, Raoua Ben Messaoud, et al.
Annals of the American Thoracic Society|September 23, 2025
Home Blood Pressure Trajectories During 6 Months of Continuous Positive Airway Pressure Therapy: Results from the eMEUSE-SANTE and SLEEPCONNECT ClinicOphélie Coiffier, Sébastien Bailly, Marie Joyeux-Faure, et al.
Pageof 2